MSB 4.07% $1.15 mesoblast limited

Ann: Mesoblast Update on Chronic Low Back Pain Program, page-322

  1. 2,237 Posts.
    lightbulb Created with Sketch. 35
    @stockrock

    I'm sure that you have not forgotten this product bubbling quietly away in the background. It's a real sleeper imo and must "soon" be scheduled to come before the FDA. It's overdue!

    The monies involved here have been noted as up to $112.5 million up-front from Grunenthal, double digit sales royalties in a billion dollar market in the EU. The bidding hasn't even begun for the U.S. market, which may double the EU market as estimated by @Longstock.

    C'mon FDA. It's on your list somewhere
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.